Companies: 10,795·Total market cap: $144.5T
Standard BioTools Inc.

Standard BioTools Inc.

LABNASDAQHealthcare● Active
$0.81
$-0.34(-29.17%)
Market Cap$317993863
P/E Ratio
52W High$1.72
52W Low$0.8081

Standard BioTools Inc. (LAB) Stock Ownership

Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.

SEC 13F · FMP · LAB · as of Mar 31, 2025

Ownership Breakdown

Institutions 72.14%
Insiders 89.07%
Public 0%

149

Institutional Holders

▲ 3 vs Q4

$304.15M

Total Inst. Value

▼ $182.93M vs Q4

390.37M

Shares Outstanding

freeFloat 10.93%

281.60M

13F Shares Held

▲ 3.23M vs Q4

Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.

Top Institutional Holders

LAB largest shareholders · institutional ownership

Q1 2025 · SEC 13F

Showing top 10 holders

HolderShares% OwnedWeightValueReportedChange

CASDIN CAPITAL, LLC

laboratory analytical instruments

76.08M20.11%

20.11%

$82.16BMay 15, 2025 4.82M

VIKING GLOBAL INVESTORS LP

laboratory analytical instruments

58.65M15.51%

15.51%

$63.34BMay 15, 2025— held

BLACKROCK, INC.

laboratory analytical instruments

24.62M6.51%

6.51%

$26.59BMay 2, 2025 237.6K

VANGUARD GROUP INC

laboratory analytical instruments

17.23M4.55%

4.55%

$18.60BMay 9, 2025 69.1K

MORGAN STANLEY

laboratory analytical instruments

10.71M2.83%

2.83%

$11.57BMay 15, 2025 6.14M

GEODE CAPITAL MANAGEMENT, LLC

laboratory analytical instruments

7.21M1.91%

1.91%

$7.78BMay 13, 2025 230.2K

LONG FOCUS CAPITAL MANAGEMENT, LLC

laboratory analytical instruments

6.70M1.77%

1.77%

$7.24BMay 15, 2025NEW

TIKVAH MANAGEMENT LLC

laboratory analytical instruments

6.55M1.73%

1.73%

$7.08BMay 13, 2025— held

STATE STREET CORP

laboratory analytical instruments

6.36M1.68%

1.68%

$6.87BMay 15, 2025 69.1K

SUMITOMO MITSUI TRUST HOLDINGS, INC.

laboratory analytical instruments

6.23M1.65%

1.65%

$6.73BApr 25, 2025 384.7K

Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).

Institutional Activity

Q1 2025 vs prior quarter

Q1 2025

Net institutional sentimentBullish — more buying than selling

18

Increased

+8.23M shares

3

New Positions

first time holders

15

Decreased

−10.27M shares

0

Sold Out

fully exited

Net shares change (top 50)

2.04M

+8.23M / −10.27M

Net new holders

+6

3 new / 0 exited

Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).

Insider Buying vs Selling

LAB insider trading · insider activity

Source: SEC Form 4

2

Buy transactions

7

Sell transactions

0.29

Buy/Sell ratio

$1M

Total disposed

Recent Insider Transactions

Showing 10 most recent · Common Stock only

Name · RoleDateTypeSharesPriceValueAfter Trans.Filing

Kim Hanjoon Alex

Chief Financial Officer

May 20, 2026Tax Withhold18,871$1.00$18.9K2.76MForm 4 ↗

Mackay Sean

SVP & Chief Business Officer

May 20, 2026Tax Withhold25,729$1.00$25.7K1.01MForm 4 ↗

Egholm Michael

President & CEO

May 20, 2026Tax Withhold97,626$1.00$97.6K6.60MForm 4 ↗

Egholm Michael

President & CEO

Apr 6, 2026Tax Withhold95,014$0.91$86.3K6.70MForm 4 ↗

Egholm Michael

President & CEO

Mar 20, 2026Award1,042,3736.59MForm 4 ↗

Egholm Michael

President & CEO

Mar 20, 2026Award2,345,340$0.98$2.31M2.35MForm 4 ↗

Mackay Sean

SVP & Chief Business Officer

Mar 20, 2026Award272,1071.03MForm 4 ↗

Mackay Sean

SVP & Chief Business Officer

Mar 20, 2026Award612,240$0.98$602.8K612.2KForm 4 ↗

Kim Hanjoon Alex

Chief Financial Officer

Apr 6, 2026Tax Withhold21,301$0.91$19.3K2.78MForm 4 ↗

Kim Hanjoon Alex

Chief Financial Officer

Mar 20, 2026Award323,1732.73MForm 4 ↗

Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.

About institutional & insider ownership

Standard BioTools Inc. (LAB) is primarily owned by institutional investors, who hold approximately 72.1% of total shares outstanding. Company insiders own approximately 89.07%, while retail and public investors account for the remaining 0.00%.

The largest institutional shareholder of Standard BioTools Inc. is CASDIN CAPITAL, LLC, holding approximately 76.08 million shares — equal to 20.11% of outstanding shares — as of March 31, 2025.

A total of 149 institutional investors currently hold LAB stock, with a combined institutional value of approximately $304,152,982 as of the most recent 13F filing period.

Frequently asked questions

LAB ownership

Standard BioTools Inc. (LAB) is primarily owned by institutional investors, who hold approximately 72.1% of shares. The largest shareholder is CASDIN CAPITAL, LLC with a 20.11% stake. Company insiders hold 89.07%. Data sourced from SEC Form 13F as of March 31, 2025.

who owns LAB stockLAB ownership structureSEC Form 13F institutional holdingsLAB float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of March 31, 2025